REGENERON PHARMAC.DL-001/ US75886F1075 /
| 2025-03-14 4:37:44 PM | Chg. -26.2000 | Volume | Bid8:58:01 PM | Ask8:58:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 611.8000EUR | -4.11% | 10 Turnover: 6,118 |
609.4000Bid Size: 20 | 614.2000Ask Size: 20 | 67 bill.EUR | - | - |
Fundamentals
| FY 2024 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 40.90 USD | 10.39% |
| EPS Diluted: | 38.34 USD | 10.27% |
| Revenues per Share: | 132.10 USD | 8.71% |
| Book Value per Share: | 273.04 USD | 13.47% |
| Cash Flow per Share: | 41.12 USD | -3.39% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 14,202.00 USD | 8.27% |
| Net Income: | 4,412.60 USD | 11.61% |
| Operating Cash Flow: | 4,420.50 USD | - |
| Cash and Cash Equivalents: | 2,488.20 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 16.30 | 17.42 |
| P/S Ratio: | 5.05 | 5.39 |
| P/BV ratio: | 2.44 | 2.61 |
| P/CF Ratio: | 16.22 | 17.32 |
| PEG: | 1.57 | 1.68 |
| Earnings Yield: | 6.13% | 5.74% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 67 bill. EUR | 73.99 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 107.51 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 28.10% |
| Net Profit Margin: | 31.07% |
| Return on Equity: | 15.03% |
| Return on Assets: | 11.69% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.63% |
| Liquidity II / Quick Ratio: | 2.21% |
| Liquidity III / Current Ratio: | 4.73% |
| Debt / Equity Ratio: | 0.09% |
| Dynam. Debt / Equity Ratio: | 190.16% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2024-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
